Product Code: ETC367104 | Publication Date: Aug 2022 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India microtomes market import shipment demonstrated a steady growth trend from 2020 to 2024, with a CAGR of 5.6%. However, there was a notable decline in growth between 2023 and 2024, showing a decrease of 7.0%. Overall, the market expanded with some signs of slowing down towards the end of the period.
The market for microtomes in India is expected to register a steady growth rate during 2025-2031 with an anticipated CAGR of 7%, owing to the increased use of advanced technologies such as cryostat and ultramicrotome among healthcare professionals coupled with upgradation from manual devices towards automated systems.
The microtomes market in India is experiencing steady growth due to its importance in histology and pathological research. One of the significant drivers for this market is the rising prevalence of chronic diseases and the need for accurate tissue analysis and diagnosis. Microtomes play a critical role in preparing thin slices of tissue samples for microscopic examination, enabling pathologists and researchers to study disease processes and identify abnormalities. The increasing investments in healthcare infrastructure and the expansion of medical research facilities are driving the demand for microtomes in India. Additionally, the development of advanced microtome models with automated features and user-friendly interfaces is attracting healthcare institutions and research laboratories, further fueling market growth.
The microtomes market in India encounters challenges despite its importance in sample preparation for histology and other scientific applications. One of the significant challenges is the transition towards automated tissue processors and advanced imaging techniques, reducing the demand for manual microtomes. Automated systems offer higher throughput and more standardized results, making them preferable in high-volume laboratories and research settings. Additionally, the availability of affordable imported microtomes from other countries may create price competition for domestic manufacturers, affecting their market share. Moreover, the need for regular maintenance and skilled operation of microtomes can pose challenges for smaller laboratories and healthcare facilities with limited resources.
The microtomes market in India was affected by the COVID-19 pandemic due to disruptions in healthcare services and research activities. With many elective surgeries postponed and research laboratories operating with limited capacity, the demand for microtomes, used for precision tissue sectioning, experienced a decline. However, as medical services resumed and research activities adapted to the new conditions, there was a gradual recovery in the market. The focus on medical research and histopathology remained essential, driving the need for reliable microtomes for sample preparation. Additionally, as the healthcare sector strengthened its infrastructure and preparedness for future pandemics, the demand for microtomes in pathology laboratories and research institutions is expected to rebound.
The microtomes market in India has been witnessing growth as histopathology and research labs demand precision cutting tools for tissue sectioning. Key players in this market include companies like Leica Biosystems Nussloch GmbH, Sakura Finetek India Pvt. Ltd., and Thermo Fisher Scientific Inc. These global players offer a range of microtomes with advanced features, ensuring efficient and precise sectioning of tissues for histological examinations. Additionally, India companies such as Advanced Technocracy Inc. also contribute to the microtomes market, providing affordable and reliable cutting solutions for smaller laboratories and educational institutions.